Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

被引:249
|
作者
Vogel, Jacob W. [1 ]
Iturria-Medina, Yasser [1 ]
Strandberg, Olof T. [2 ]
Smith, Ruben [2 ,3 ]
Levitis, Elizabeth [1 ]
Evans, Alan C. [1 ]
Hansson, Oskar [2 ,3 ]
机构
[1] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
[2] Lund Univ, Clin Memory Res Unit, Lund, Sweden
[3] Skane Univ Hosp, Memory Clin, Lund, Sweden
基金
加拿大健康研究院; 瑞典研究理事会; 美国国家卫生研究院; 欧洲研究理事会;
关键词
COGNITIVE DECLINE; IN-VIVO; NEURODEGENERATIVE DISEASES; F-18-AV-1451; PET; MODEL; DEPOSITION; BINDING; PROPAGATION; ASSOCIATION; CONNECTOME;
D O I
10.1038/s41467-020-15701-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tau is a hallmark pathology of Alzheimer's disease, and animal models have suggested that tau spreads from cell to cell through neuronal connections, facilitated by beta -amyloid (A beta). We test this hypothesis in humans using an epidemic spreading model (ESM) to simulate tau spread, and compare these simulations to observed patterns measured using tau-PET in 312 individuals along Alzheimer's disease continuum. Up to 70% of the variance in the overall spatial pattern of tau can be explained by our model. Surprisingly, the ESM predicts the spatial patterns of tau irrespective of whether brain A beta is present, but regions with greater A beta burden show greater tau than predicted by connectivity patterns, suggesting a role of A beta in accelerating tau spread. Altogether, our results provide evidence in humans that tau spreads through neuronal communication pathways even in normal aging, and that this process is accelerated by the presence of brain A beta. The tau protein is theorized to spread transneuronally in Alzheimers disease, though this theory remains unproven in humans. Our simulations of epidemic-like protein spreading across human brain networks support this theory, and suggest the spreading dynamics are modified by beta -amyloid
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Lactylation of tau in human Alzheimer's disease brains
    Zhang, Xiaoyu
    Liu, Yan
    Rekowski, Michaella J.
    Wang, Ning
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [22] Spread of pathological human Tau from neurons to oligodendrocytes and loss of high-firing pyramidal neurons in aging mice
    Viney, Tim J.
    Sarkany, Barbara
    Ozdemir, A. Tugrul
    Hartwich, Katja
    Schweimer, Judith
    Bannerman, David
    Somogyi, Peter
    CELL REPORTS, 2022, 41 (07):
  • [23] Development of inhibitors of pathological tau hyperphosphorylation for a disease modifying approach to Alzheimer's disease
    Sahagun, H
    Hübinger, G
    Klafki, H
    Gordon, S
    Ferrand, S
    Mülbacher, S
    Müller, S
    Seneci, P
    Monse, B
    Fröhner, W
    Casiraghi, L
    Thillaye du Boullay, O
    Braxmeier, T
    LeCorre, S
    Dirscherl, L
    Jolivalt, C
    Lahu, G
    Sobek-Klocke, I
    Plesnila, N
    Hutton, M
    Roder, H
    NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2005, 2005, : 71 - 76
  • [24] Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention
    Insel, Philip S.
    Mormino, Elizabeth C.
    Aisen, Paul S.
    Thompson, Wesley K.
    Donohue, Michael C.
    BRAIN COMMUNICATIONS, 2020, 2 (01)
  • [25] Pathological tau proteins in argyrophilic grain disease
    Simic, G
    LANCET NEUROLOGY, 2002, 1 (05): : 276 - 276
  • [26] In vitro molecular reconstruction of the pathological truncation of tau protein in Alzheimer's disease
    Ovecka, M
    Novak, M
    Cattaneo, A
    CHEMICAL PAPERS, 1998, 52 : 315 - 315
  • [27] Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
    Sigurdsson, Einar M.
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 15 (02) : 157 - 168
  • [28] Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies
    Irwin, David J.
    Cohen, Todd J.
    Grossman, Murray
    Arnold, Steven E.
    Xie, Sharon X.
    Lee, Virginia M. -Y.
    Trojanowski, John Q.
    BRAIN, 2012, 135 : 807 - 818
  • [29] Acetylated Tau, a Novel Pathological Signature in Alzheimer's Disease and Other Tauopathies
    Irwin, David J.
    Cohen, Todd
    Grossman, Murray
    Arnold, Steven E.
    Xie, Sharon X.
    Lee, Virginia M. Y.
    Trojanowski, John Q.
    ANNALS OF NEUROLOGY, 2011, 70 : S89 - S89
  • [30] Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer's disease
    Shim, Kyu Hwan
    Kang, Min Ju
    Youn, Young Chul
    An, Seong Soo A.
    Kim, SangYun
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)